Novan, Inc.

Novan, Inc.verified

NOVN

Price:

$0.0941

Market Cap:

$2.64M

Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. Its clinical stage dermatology drug candidates include SB204, a topical monotherapy for the treatment of acne vulgaris; SB206, a topical anti-viral gel for the treatment of viral skin infections; SB208, a topical broad-spectrum anti-fungal gel for the treatment of fungal infections of the skin and nails, including athlete's foot and fungal nail infections; and SB414, a topical cream-based gel product candidate for the treatment of inflammatory skin diseases. The company also develops SB207, an anti-viral product candidate for the treatment of external genital warts; W...[Read more]

Industry

Biotechnology

IPO Date

2016-09-21

Stock Exchange

NASDAQ

Ticker

NOVN

The PE Ratio as of June 2024 (TTM) for Novan, Inc. (NOVN) is -0.11

According to Novan, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.11. This represents a change of -92.87% compared to the average of -1.57 of the last 4 quarters.

Novan, Inc. (NOVN) Historical PE Ratio (quarterly & annually)

How has NOVN PE Ratio performed in the past?

The mean historical PE Ratio of Novan, Inc. over the last ten years is -4.07. The current -0.11 PE Ratio has changed 175.54% with respect to the historical average. Over the past ten years (40 quarters), NOVN's PE Ratio was at its highest in in the December 2022 quarter at 0.30. The PE Ratio was at its lowest in in the September 2015 quarter at -8.32.

Quarterly (TTM)
Annual

Average

-4.07

Median

-2.57

Minimum

-17.76

Maximum

0

Novan, Inc. (NOVN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Novan, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 59.55%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -17.76

Quarterly (TTM)
Annual
YearPE RatioChange
2022-1.64-33.40%
2021-2.47-7.34%
2020-2.66-1.20%
2019-2.7059.55%
2018-1.69-6.99%
2017-1.82-32.95%
2016-2.71-62.42%
2015-7.21-59.42%
2014-17.76-Infinity%

Novan, Inc. (NOVN) Average PE Ratio

How has NOVN PE Ratio performed in the past?

The current PE Ratio of Novan, Inc. (NOVN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.26

5-year avg

-2.23

10-year avg

-4.07

Novan, Inc. (NOVN) PE Ratio vs. Peers

How is NOVN’s PE Ratio compared to its peers?

Novan, Inc.’s PE Ratio is greater than Tarsus Pharmaceuticals, Inc. (-6.50), greater than LianBio (-0.39), greater than Aldeyra Therapeutics, Inc. (-7.19), greater than Travere Therapeutics, Inc. (-3.40), less than Eton Pharmaceuticals, Inc. (91.99), greater than Tonix Pharmaceuticals Holding Corp. (-1.00), greater than Jaguar Health, Inc. (-16.21), greater than Acasti Pharma Inc. (-0.97), less than Diffusion Pharmaceuticals Inc. (-0.00), greater than iBio, Inc. (-0.37), less than Aditxt, Inc. (-0.06), greater than Palisade Bio, Inc. (-0.27), greater than Plus Therapeutics, Inc. (-0.71), greater than Revelation Biosciences, Inc. (-0.28), greater than Quoin Pharmaceuticals, Ltd. (-0.15), greater than Onconova Therapeutics, Inc. (-1.15), greater than Adial Pharmaceuticals, Inc. (-0.43), less than Aeterna Zentaris Inc. (-0.10), greater than Lyra Therapeutics, Inc. (-0.24), greater than Trevi Therapeutics, Inc. (-7.98), greater than SQZ Biotechnologies Company (-3.78), greater than Protara Therapeutics, Inc. (-0.63), less than TRACON Pharmaceuticals, Inc. (1.76),

Build a custom stock screener for Novan, Inc. (NOVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novan, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Novan, Inc. (NOVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Novan, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Novan, Inc.'s PE Ratio?

How is the PE Ratio calculated for Novan, Inc. (NOVN)?

What is the highest PE Ratio for Novan, Inc. (NOVN)?

What is the 3-year average PE Ratio for Novan, Inc. (NOVN)?

What is the 5-year average PE Ratio for Novan, Inc. (NOVN)?

How does the current PE Ratio for Novan, Inc. (NOVN) compare to its historical average?